Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 10-(3-(diethylamino)-1-oxopropyl)-10h-(phenothiazin-2-yl)carbamic Acid Ethyl Ester
2. 2-(ethoxycarbonylamino)-10-(3-(diethylamino)propionyl)phenothiazine
3. Etacizin
4. Etacyzine
5. Etatsizin
6. Etatsizine
7. Nik 244
8. Nik0244
1. Etacizin
2. Ethacizin
3. Ethacyzin
4. 33414-33-4
5. Etmozine Daa
6. Nik-244
7. Fe5spv1z6g
8. Nsc-621878
9. Ethyl N-[10-[3-(diethylamino)propanoyl]phenothiazin-2-yl]carbamate
10. Ez-55
11. Ethmozine Daa
12. Ez 55
13. Unii-fe5spv1z6g
14. Brn 4827533
15. Ethyl (10-(3-(diethylamino)-1-oxopropyl)-10h-phenothiazin-2-yl)carbamate
16. Phenothiazine-2-carbamic Acid, 10-(n,n-diethyl-beta-alanyl)-, Ethyl Ester
17. Ethacizine [mart.]
18. Ethacizine [who-dd]
19. Oprea1_817639
20. Chembl1997663
21. Schembl22882766
22. Dtxsid50187057
23. Chebi:134732
24. Zinc4182572
25. Nsc621878
26. Stk995917
27. Akos001680764
28. Db13645
29. Nsc 621878
30. Carbamic Acid, (10-(3-(diethylamino)-1-oxopropyl)-10h-phenothiazin-2-yl)-, Ethyl Ester
31. Nci60_006381
32. D10503
33. Q15408408
34. Ethyl [10-(n,n-diethyl-beta-alanyl)-10h-phenothiazin-2-yl]carbamate
35. Ethyl 10-(3-(diethylamino)propionyl)phenothiazine-2-carbamate
36. Ethyl N-{10-[3-(diethylamino)propanoyl]-10h-phenothiazin-2-yl}carbamate
37. 4596-66-1
Molecular Weight | 413.5 g/mol |
---|---|
Molecular Formula | C22H27N3O3S |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 8 |
Exact Mass | 413.17731291 g/mol |
Monoisotopic Mass | 413.17731291 g/mol |
Topological Polar Surface Area | 87.2 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 557 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)
C - Cardiovascular system
C01 - Cardiac therapy
C01B - Antiarrhythmics, class i and iii
C01BC - Antiarrhythmics, class ic
C01BC09 - Ethacizine
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?